BRNS stock

Barinthus Biotherapeutics plc (BRNS) financials · $38.2M cap

Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT

Barinthus Biotherapeutics plc (BRNS) $38.2M cap.

Cached annual income statement
LineFY2025FY2024
RevenueN/A$15.0M
Operating Income-$70.6M-$68.0M
Net Income-$66.4M-$61.1M
EPS (Diluted)-$1.64-$1.55
Cached annual balance sheet
LineFY2025FY2024
Total Assets$98.2M$160.3M
Current Assets$77.8M$125.7M
Cash & Equivalents$70.5M$110.7M
PP&E$3.52M$7.37M
Total Liabilities$23.9M$30.2M
Current Liabilities$10.0M$15.7M
Shareholders' Equity$74.2M$130.0M
Retained Earnings-$304.1M-$237.7M
Cached annual cash flow
LineFY2025FY2024
Operating Cash Flow-$48.0M-$28.9M
CapEx$37.0K$892.0K
Investing Cash Flow$416.0K-$892.0K
Financing Cash Flow$2.00K$2.16M
Net Change in Cash-$40.5M-$29.7M
Free Cash Flow-$48.0M-$29.8M
These statements as JSON? API free 100/day

FAQ

What is BRNS P/E and revenue?

Barinthus Biotherapeutics plc (BRNS) $38.2M cap.

What is BRNS revenue?

BRNS income-statement cache has no revenue figure yet.

Is BRNS profitable?

Barinthus Biotherapeutics plc last cached net income is -$66.4M (FY2025).

What are BRNS total assets?

Barinthus Biotherapeutics plc last cached total assets are $98.2M (FY2025).

What is BRNS free cash flow?

Barinthus Biotherapeutics plc last cached free cash flow is -$48.0M (FY2025).

Not investment advice. Cached statements, not a live tape.